Efficacy News and Research

RSS
XenoPort to present arbaclofen placarbil, XP13512 trial data at 62nd American Academy of Neurology meeting

XenoPort to present arbaclofen placarbil, XP13512 trial data at 62nd American Academy of Neurology meeting

Rib-X Pharmaceuticals to present delafloxacin Phase 2 study data at 20th ECCMID

Rib-X Pharmaceuticals to present delafloxacin Phase 2 study data at 20th ECCMID

Inhibitex provides update on ongoing Phase II clinical trial of FV-100 for shingles

Inhibitex provides update on ongoing Phase II clinical trial of FV-100 for shingles

Competitive Technologies to introduce Calmare pain therapy at medical conference

Competitive Technologies to introduce Calmare pain therapy at medical conference

Clinical and preclinical malaria vaccine data presented at Keystone Symposium

Clinical and preclinical malaria vaccine data presented at Keystone Symposium

Oceana Therapeutics, Q-Med submit Solesta PMA application for treatment of fecal incontinence

Oceana Therapeutics, Q-Med submit Solesta PMA application for treatment of fecal incontinence

Global study shows wide variations in treatment of women with early breast cancer

Global study shows wide variations in treatment of women with early breast cancer

Combating a frequently overlooked assassin: Water

Combating a frequently overlooked assassin: Water

OptiMedica releases new details on femtosecond laser system for cataract surgery

OptiMedica releases new details on femtosecond laser system for cataract surgery

Study suggests new ways to improve anti-cancer chemotherapies

Study suggests new ways to improve anti-cancer chemotherapies

GE Healthcare to present results of phase 2 study of flutemetamol at HAI Meeting

GE Healthcare to present results of phase 2 study of flutemetamol at HAI Meeting

Cempra to make poster presentations on CEM-101 and CEM-102 at ECCMID 2010

Cempra to make poster presentations on CEM-101 and CEM-102 at ECCMID 2010

MaxCyte, Medinet agree to amend License, Development and Supply Agreement

MaxCyte, Medinet agree to amend License, Development and Supply Agreement

AED Vimpat to be the subject of numerous studies and analyses at AAN meeting

AED Vimpat to be the subject of numerous studies and analyses at AAN meeting

Research roundup: The effects of health IT, doctor-owned treatment centers, long-term care issues

Research roundup: The effects of health IT, doctor-owned treatment centers, long-term care issues

Gamma-tocotrienol kills prostate tumour cells in animal model studies

Gamma-tocotrienol kills prostate tumour cells in animal model studies

Catalyst Pharmaceutical Partners' vigabatrin data to be presented at 41st ASAM conference

Catalyst Pharmaceutical Partners' vigabatrin data to be presented at 41st ASAM conference

Tβ4 therapy for ocular disorders closer to reality

Tβ4 therapy for ocular disorders closer to reality

Non-psychoactive cannabis to be unveiled at Annual National Clinical Conference on Cannabis Therapeutics

Non-psychoactive cannabis to be unveiled at Annual National Clinical Conference on Cannabis Therapeutics

Investment report on Somaxon Pharmaceuticals

Investment report on Somaxon Pharmaceuticals

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.